The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More Post author:Sam Post published:November 21, 2017 Post category:BioPharma Keith Speights, writing for The Motley Fool, notes one biotech that’s booming. Source: BioSpace You Might Also Like Checkmate Notches $27 Million and Taps Ex-FORUM Pharma Exec as COO June 15, 2017 First Patients Treated With ViewRay's MRIdian Linac System At July 19, 2017 How Celgene Could Reap Huge Rewards From This Tiny Biotech November 16, 2017
